Intervention not reported
Hypertension · CKD patients (any stage) treated for anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: hypertension · anaemia in predialysis patients
Epoetin alfa every four weeks showed no clear difference in adverse events: hypertension compared with with every two weeks (moderate certainty).
1 finding from 1 review
Adverse events: hypertension · anaemia in predialysis patients
Epoetin theta showed no clear difference in adverse events: hypertension compared with epoetin beta (moderate certainty).
1 finding from 1 review
Adverse events: hypertension · anaemia in predialysis patients
Epoetin alpha every 2 weeks showed no clear difference in adverse events: hypertension compared with to weekly (moderate certainty).
1 finding from 1 review
Dizziness or hypotension · dialysis patients with depression
1 finding from 1 review
Intervention not reported
Hypotensive events · patients with acute kidney injury
The intervention probably leads to lower hypotensive events (moderate certainty).
1 finding from 1 review
Intervention not reported
ICU ‐ intensive care unit · adults undergoing surgery requiring cardiac bypass
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Numbers of adverse effects due to hypertension · patients with the anaemia of end‐stage kidney disease undergoing dialysis
The intervention showed no clear difference in numbers of adverse effects due to hypertension (high certainty).
1 finding from 1 review
Hypertension · patients with the anaemia of end‐stage kidney disease undergoing dialysis
1 finding from 1 review
Adverse events: hypertension · patients with the anaemia of end‐stage kidney disease undergoing dialysis
1 finding from 1 review
Adverse events: hypertension · patients with the anaemia of end‐stage kidney disease undergoing dialysis
CERA showed no clear difference in numbers of adverse events due to hypertension: CERA every 2 weeks… compared with other ESA (high certainty).
1 finding from 1 review
Hypertension · lung transplant recipients
Tacrolimus may leads to lower arterial hypertension compared with cyclosporin (low certainty).
1 finding from 1 review
Other side effects · people with CKD requiring dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Predialysis systolic blood pressure · people with CKD requiring dialysis
1 finding from 1 review
Diastolic blood pressure · people with CKD requiring dialysis
1 finding from 1 review
Cardiovascular mortality · people with CKD requiring dialysis
1 finding from 1 review
Kidney failure · proteinuric CKD
It is very uncertain whether aldosterone antagonists changes kidney failure compared with placebo or standard care (very low certainty).
1 finding from 1 review
Hyperkalaemia · proteinuric CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death · proteinuric CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular events · proteinuric CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found